Boyang worked on the AngioChip as part of his PhD studies in the Chemical Engineering department at U of T. The chip offers a way to vascularize tissue with a permeable, mechanically stable polymer vascular bed. Zhang is currently part of a team of researchers hand building AngioChip platforms, which have potential to be used for drug discovery and regenerative medicine. He explained, “Engineering vascular networks within a functional tissue is essential to achieve high fidelity organ-on-a-chip models on the micro-scale as well as for the clinical success of solid tissue replacements on the macro-scale.” Read full story.
Congratulations to Boyang! MDDI Online has named Boyang Zhang (PhD 1T4) as a rising star in the medical technology sector.July 28th, 2016 by laschinger
Professor Milica Radisic has been announced as the lead recipient of a major research grant from the Natural Sciences and Engineering Research Council of Canada (NSERC). The funding will help train the next generation of experts in new treatments for disease based on lab-grown human tissues.